Anika Therapeutics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2025. For the third quarter, the company reported sales was USD 27.82 million compared to USD 29.56 million a year ago. Net loss was USD 2.33 million compared to USD 29.92 million a year ago. Basic loss per share from continuing operations was USD 0.22 compared to USD 0.12 a year ago. Diluted loss per share from continuing operations was USD 0.22 compared to USD 0.12 a year ago. Basic loss per share was USD 0.16 compared to USD 2.03 a year ago. Diluted loss per share was USD 0.16 compared to USD 2.03 a year ago.
For the nine months, sales was USD 82.2 million compared to USD 89.31 million a year ago. Net loss was USD 11.17 million compared to USD 34.52 million a year ago. Basic loss per share from continuing operations was USD 0.82 compared to USD 0.43 a year ago. Diluted loss per share from continuing operations was USD 0.82 compared to USD 0.43 a year ago. Basic loss per share was USD 0.78 compared to USD 2.34 a year ago. Diluted loss per share was USD 0.78 compared to USD 2.34 a year ago.
Anika Therapeutics, Inc. is a global joint preservation company. The Company creates and delivers advancements in early intervention orthopedic care, including in the areas of osteoarthritis (OA) pain management, regenerative solutions, and sports medicine. It is focused on developing, manufacturing and commercializing products on its hyaluronic acid (HA), technology platform. Its OA Pain Management product family consists of Monovisc and Orthovisc, its injectable, HA, OA Pain Management offerings are indicated to provide pain relief from osteoarthritis conditions; and Cingal, its novel, next generation, single-injection OA Pain Management product consisting of its proprietary cross-linked HA material combined with a steroid. Its Joint Preservation and Restoration product family consists of its portfolio of orthopedic regenerative solutions products utilizing HA, including Integrity, its new hyaluronic acid-based scaffold for rotator cuff and other tendon repairs.
